Acute disseminated encephalomyelitis

S Tenembaum, T Chitnis, J Ness, JS Hahn - Neurology, 2007 - AAN Enterprises
Acute disseminated encephalomyelitis (ADEM) is an immune-mediated inflammatory
disorder of the CNS characterized by a widespread demyelination that predominantly …

Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: a systematic review

F Nabizadeh, M Noori, S Rahmani… - Journal of Clinical …, 2023 - Elsevier
Background Although global vaccination against COVID-19 infection has its excellence,
potential side effects are yet of concern. Several lines of evidence have proposed ADEM …

Retrospective observational study of brain MRI findings in patients with acute SARS-CoV-2 infection and neurologic manifestations

L Chougar, N Shor, N Weiss, D Galanaud, D Leclercq… - Radiology, 2020 - pubs.rsna.org
Background This study provides a detailed imaging assessment in a large series of patients
infected with coronavirus disease 2019 (COVID-19) and presenting with neurologic …

Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Apheresis Applications Committee of the American Society for …

ZM Szczepiorkowski, JL Winters… - Journal of clinical …, 2010 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Apheresis Applications Committee is
charged with a review and categorization of indications for therapeutic apheresis. Beginning …

Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases

A Langer-Gould, L Qian, SY Tartof, SM Brara… - JAMA …, 2014 - jamanetwork.com
Importance Because vaccinations are common, even a small increased risk of multiple
sclerosis (MS) or other acquired central nervous system demyelinating syndromes (CNS …

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

KC O'Connor, KA McLaughlin, PL De Jager, T Chitnis… - Nature medicine, 2007 - nature.com
The role of autoantibodies in the pathogenesis of multiple sclerosis (MS) and other
demyelinating diseases is controversial, in part because widely used western blotting and …

MRI criteria for MS in patients with clinically isolated syndromes

X Montalban, M Tintore, J Swanton, F Barkhof… - Neurology, 2010 - AAN Enterprises
In recent years, criteria for the diagnosis of multiple sclerosis (MS) have changed, mainly
due to the incorporation of new MRI criteria. While the new criteria are a logical step forward …

Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation

JM Gelfand - Handbook of clinical neurology, 2014 - Elsevier
The diagnosis of multiple sclerosis (MS) is based on demonstrating evidence of
inflammatory-demyelinating injury within the central nervous system that is disseminated in …

Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease

F Brilot, RC Dale, RC Selter, V Grummel… - Annals of Neurology …, 2009 - Wiley Online Library
Objective Myelin oligodendrocyte glycoprotein (MOG) is a candidate target antigen in
demyelinating diseases of the central nervous system (CNS). Although MOG is …

[HTML][HTML] Retrospective observational study of brain magnetic resonance imaging findings in patients with acute SARS-CoV-2 infection and neurological manifestations

L Chougar, N Shor, N Weiss, D Galanaud, D Leclercq… - Radiology, 2020 - ncbi.nlm.nih.gov
Retrospective Observational Study of Brain Magnetic Resonance Imaging Findings in Patients
with Acute SARS-CoV-2 Infection and Neurological Manifestations - PMC Back to Top Skip to …